利用药理动力学/药理动力学方法优化和加速创新抗感染药物的药物开发
1Department of Chemical Biology, Helmholtz Centre for Infection Research (HZI), Inhoffenstrasse 7, 38124, Braunschweig, Germany.
ChemMedChem
|January 31, 2026
概括
加快抗微生物和抗病毒药物开发是至关重要的. 药理动力学/药理动力学 (PK/PD) 方法优化了传统和新型抗感染药物的临床前阶段,解决了耐药性和新出现的病毒.
科学领域:
- 药理学和药物开发领域
- 传染性疾病 传染性疾病
- 生物化学 生物化学
背景情况:
- 抗菌素耐药性增加和新型病毒大流行的可能性需要加速药物开发.
- 降低消耗风险至关重要,以确保新的抗感染药物有效地到达患者.
- 克服新型抗感染药物的翻译障碍需要优化临床前策略.
研究的目的:
- 审查药理动力学/药理动力学 (PK/PD) 方法的最新进展,以优化临床前抗感染药物开发.
- 强调PK/PD对传统抗菌/抗病毒药物和新型抗感染策略的考虑.
- 为非传统的抗感染方法所带来的PK/PD挑战提出解决方案.
主要方法:
- 关于PK/PD在临床前药物开发中的应用现有文献的综述.
- 对PK/PD原理的分析,应用于古典抗菌剂和抗病毒药物.
- 探索新型抗感染药物的PK/PD挑战和策略 (例如,蛋白质溶解向的嵌合体,抗病毒概念).
主要成果:
- PK/PD 建模为优化抗感染药物的临床前开发提供了显著的潜力.
- 新型抗感染策略带来了独特的PK/PD挑战,需要量身定制的方法.
- 适应传统的PK/PD框架可以为开发非传统的抗感染药物提供见解.
结论:
- 优化PK/PD方法对于加速开发有效的抗微生物和抗病毒疗法至关重要.
- 在新型抗感染方式中解决PK/PD复杂性对于成功的临床转化至关重要.
- 利用现有的PK/PD知识可以引导开发针对传染病的创新解决方案.
相关概念视频
01:20Measurement of Bioavailability: Pharmacodynamic Methods
745
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
745
01:25Pharmacokinetics: Drug–Drug Interactions
446
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
446
01:26Pharmacokinetics: Drug–Food and Drug–Viral Interactions
252
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
252
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
261
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
01:30Measurement of Bioavailability: Pharmacokinetic Methods
289
Pharmacokinetics is a vital branch of pharmacology that examines how drugs are absorbed, distributed, metabolized, and excreted by the body. Two key methodologies in pharmacokinetics are plasma drug concentration studies and urinary drug excretion analyses, both of which provide critical insights into a drug's therapeutic efficacy and bioavailability.Plasma Drug Concentration-Time StudiesPlasma drug concentration-time studies involve analyzing blood samples at specific intervals to quantify...
289
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
307
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307